HealthtechStartups

eSteps Introduces Smart Insole for Detecting Neurological Diseases

The healthcare market is witnessing tremendous growth due to an aging population and increasing demand for personalized health solutions. According to Statista, this market is expected to grow by more than 60% by 2025, reaching approximately 78 billion euros.

The startup eSteps is aiming to revolutionize the healthcare industry by introducing a smart insole capable of detecting early signs of neurological diseases. This insole collects precise data on the user’s movements and gait, which is then analyzed by a dedicated app to provide personalized recommendations. Athletes and fitness enthusiasts can also benefit from this device. With this advanced technology, eSteps is well-positioned to become a major player in the healthcare sector. As a result, the company has already established strategic partnerships with key players in the healthcare industry in the United States and Europe.

eSteps originated from academic research conducted by Nidhal Louhichi at the University of Bologna in Italy and became a startup in 2020. In March 2022, the company relocated its headquarters to Boston, allowing it to access the world’s largest digital health hub. Since then, eSteps has received support from EXOR Ventures and 216 Capital. EXOR Ventures provided its strategic vision for the healthcare sector, while 216 Capital helped expand the company’s activities in North Africa, particularly in Tunisia.

According to Zekra Al-Khalifi, a partner at 216 Capital, their investment in eSteps was driven by a deep belief in its positive impact on improving people’s lives. She added, “We believe in eSteps’ transformative potential. Our investment in this company reflects our commitment to supporting technological advancements that improve patient outcomes, enhance healthcare professionals’ capabilities, and contribute to a better life for all.”

eSteps aspires to become a global leader in healthcare for patients with neurological diseases. The company aims to develop new products and services, including mobile applications and data platforms, to provide a comprehensive health experience for its users.

Read Also: Link Closes Seed Funding Round of $1.6 Million

Related Articles

Back to top button